US Stock MarketDetailed Quotes

NRX Pharmaceuticals (NRXP)

Watchlist
  • 2.340
  • +0.080+3.54%
Close Jan 22 16:00 ET
69.28MMarket Cap-1.01P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NRX Pharmaceuticals (NRXP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-25.46%-2.89M
-57.18%-4.03M
5.18%-3.48M
50.88%-10.64M
34.27%-2.1M
49.47%-2.31M
67.20%-2.56M
39.71%-3.67M
45.52%-21.66M
61.63%-3.19M
Net income from continuing operations
-262.91%-5.89M
-122.62%-17.58M
15.56%-5.51M
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
Operating gains losses
-2,247.27%-3.87M
46,144.44%8.29M
-388.89%-26K
14,775.00%2.94M
44,314.29%3.11M
-534.62%-165K
-263.64%-18K
175.00%9K
92.16%-20K
136.84%7K
Depreciation and amortization
2,050.00%43K
--0
--0
0.00%5K
0.00%1K
0.00%2K
0.00%1K
0.00%1K
25.00%5K
0.00%1K
Other non cash items
1,028.64%6.19M
158.74%5.71M
543.40%2.05M
95.20%5.77M
4,597.70%3.91M
-285.79%-667K
141.84%2.21M
-82.05%318K
172.53%2.96M
-117.23%-87K
Change In working capital
1,218.60%567K
-116.93%-516K
--0
2.46%5.29M
-103.55%-86K
-94.70%43K
640.25%3.05M
-8.30%2.29M
638.77%5.16M
261.49%2.42M
-Change in prepaid assets
-58.58%227K
103.12%28K
-36.40%159K
-83.45%503K
-59.42%603K
-13.29%548K
-308.35%-898K
-49.08%250K
581.01%3.04M
83.23%1.49M
-Change in payables and accrued expense
177.43%391K
-113.79%-544K
-107.81%-159K
125.42%4.79M
-173.61%-689K
-380.56%-505K
496.48%3.95M
1.70%2.04M
59.58%2.12M
763.83%936K
Cash from discontinued investing activities
Operating cash flow
-25.37%-2.89M
-57.22%-4.03M
5.20%-3.48M
50.88%-10.64M
34.27%-2.1M
49.47%-2.31M
67.20%-2.56M
39.71%-3.67M
45.52%-21.66M
61.63%-3.19M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
0
70.00%-3K
0.00%1K
Net PPE purchase and sale
----
----
--0
--0
--0
--0
--0
--0
70.00%-3K
0.00%1K
Cash from discontinued investing activities
Investing cash flow
----
----
--0
--0
--0
--0
--0
--0
70.00%-3K
0.00%1K
Financing cash flow
Cash flow from continuing financing activities
373.56%9.73M
-55.75%1.39M
1,820.25%7.59M
20.71%7.49M
269.80%1.9M
236.84%2.05M
-49.93%3.14M
-84.48%395K
-80.75%6.2M
-111.03%-1.12M
Net issuance payments of debt
-156.70%-575K
37,900.00%378K
317.17%4.68M
51.62%-1.5M
179.21%884K
91.62%-224K
-100.14%-1K
---2.16M
-132.54%-3.09M
-111.14%-1.12M
Net common stock issuance
4,444.29%9.95M
-67.79%1.01M
27.65%3.26M
-27.22%5.91M
--0
--219K
-43.66%3.14M
0.20%2.55M
-64.22%8.12M
--0
Net preferred stock issuance
----
----
----
--0
--0
----
----
----
--1.17M
--0
Proceeds from stock option exercised by employees
----
----
----
--3.97M
----
----
----
----
--0
----
Net other financing activities
--349K
--0
---350K
---896K
---2.96M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
373.52%9.73M
-55.75%1.39M
1,820.25%7.59M
20.71%7.49M
269.80%1.9M
236.84%2.05M
-49.93%3.14M
-84.48%395K
-80.75%6.2M
-111.03%-1.12M
Net cash flow
Beginning cash position
53.32%2.91M
320.62%5.55M
-68.60%1.44M
-77.09%4.6M
-81.51%1.65M
-87.32%1.9M
-92.01%1.32M
-77.09%4.6M
-27.35%20.05M
-51.22%8.9M
Current changes in cash
1,796.03%4.27M
-555.61%-2.64M
225.31%4.11M
79.61%-3.15M
95.29%-203K
95.85%-252K
137.67%579K
7.67%-3.28M
-104.73%-15.46M
-338.61%-4.31M
End cash Position
336.45%7.18M
53.32%2.91M
320.62%5.55M
-68.60%1.44M
-68.60%1.44M
-81.51%1.65M
-87.32%1.9M
-92.01%1.32M
-77.09%4.6M
-77.09%4.6M
Free cash flow
-25.37%-2.89M
-57.22%-4.03M
5.20%-3.48M
50.89%-10.64M
34.25%-2.1M
49.50%-2.31M
67.20%-2.56M
39.75%-3.67M
45.53%-21.66M
61.63%-3.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -25.46%-2.89M-57.18%-4.03M5.18%-3.48M50.88%-10.64M34.27%-2.1M49.47%-2.31M67.20%-2.56M39.71%-3.67M45.52%-21.66M61.63%-3.19M
Net income from continuing operations -262.91%-5.89M-122.62%-17.58M15.56%-5.51M16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M24.16%-30.15M57.70%-4.33M
Operating gains losses -2,247.27%-3.87M46,144.44%8.29M-388.89%-26K14,775.00%2.94M44,314.29%3.11M-534.62%-165K-263.64%-18K175.00%9K92.16%-20K136.84%7K
Depreciation and amortization 2,050.00%43K--0--00.00%5K0.00%1K0.00%2K0.00%1K0.00%1K25.00%5K0.00%1K
Other non cash items 1,028.64%6.19M158.74%5.71M543.40%2.05M95.20%5.77M4,597.70%3.91M-285.79%-667K141.84%2.21M-82.05%318K172.53%2.96M-117.23%-87K
Change In working capital 1,218.60%567K-116.93%-516K--02.46%5.29M-103.55%-86K-94.70%43K640.25%3.05M-8.30%2.29M638.77%5.16M261.49%2.42M
-Change in prepaid assets -58.58%227K103.12%28K-36.40%159K-83.45%503K-59.42%603K-13.29%548K-308.35%-898K-49.08%250K581.01%3.04M83.23%1.49M
-Change in payables and accrued expense 177.43%391K-113.79%-544K-107.81%-159K125.42%4.79M-173.61%-689K-380.56%-505K496.48%3.95M1.70%2.04M59.58%2.12M763.83%936K
Cash from discontinued investing activities
Operating cash flow -25.37%-2.89M-57.22%-4.03M5.20%-3.48M50.88%-10.64M34.27%-2.1M49.47%-2.31M67.20%-2.56M39.71%-3.67M45.52%-21.66M61.63%-3.19M
Investing cash flow
Cash flow from continuing investing activities 00000070.00%-3K0.00%1K
Net PPE purchase and sale ----------0--0--0--0--0--070.00%-3K0.00%1K
Cash from discontinued investing activities
Investing cash flow ----------0--0--0--0--0--070.00%-3K0.00%1K
Financing cash flow
Cash flow from continuing financing activities 373.56%9.73M-55.75%1.39M1,820.25%7.59M20.71%7.49M269.80%1.9M236.84%2.05M-49.93%3.14M-84.48%395K-80.75%6.2M-111.03%-1.12M
Net issuance payments of debt -156.70%-575K37,900.00%378K317.17%4.68M51.62%-1.5M179.21%884K91.62%-224K-100.14%-1K---2.16M-132.54%-3.09M-111.14%-1.12M
Net common stock issuance 4,444.29%9.95M-67.79%1.01M27.65%3.26M-27.22%5.91M--0--219K-43.66%3.14M0.20%2.55M-64.22%8.12M--0
Net preferred stock issuance --------------0--0--------------1.17M--0
Proceeds from stock option exercised by employees --------------3.97M------------------0----
Net other financing activities --349K--0---350K---896K---2.96M--------------------
Cash from discontinued financing activities
Financing cash flow 373.52%9.73M-55.75%1.39M1,820.25%7.59M20.71%7.49M269.80%1.9M236.84%2.05M-49.93%3.14M-84.48%395K-80.75%6.2M-111.03%-1.12M
Net cash flow
Beginning cash position 53.32%2.91M320.62%5.55M-68.60%1.44M-77.09%4.6M-81.51%1.65M-87.32%1.9M-92.01%1.32M-77.09%4.6M-27.35%20.05M-51.22%8.9M
Current changes in cash 1,796.03%4.27M-555.61%-2.64M225.31%4.11M79.61%-3.15M95.29%-203K95.85%-252K137.67%579K7.67%-3.28M-104.73%-15.46M-338.61%-4.31M
End cash Position 336.45%7.18M53.32%2.91M320.62%5.55M-68.60%1.44M-68.60%1.44M-81.51%1.65M-87.32%1.9M-92.01%1.32M-77.09%4.6M-77.09%4.6M
Free cash flow -25.37%-2.89M-57.22%-4.03M5.20%-3.48M50.89%-10.64M34.25%-2.1M49.50%-2.31M67.20%-2.56M39.75%-3.67M45.53%-21.66M61.63%-3.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -